EUVIMEDEUVIMED entdecken
VergleichsstudieLeitlinieOpen Access

Guideline-concordant breast cancer care by patient race and ethnicity accounting for individual-, facility- and area-level characteristics: a SEER-Medicare study

Emma L Herbach, Michaela Curran, Mya L Roberson, Ryan M Carnahan, Bradley D McDowell, Kai Wang, Ingrid Lizarraga, Sarah H Nash, Mary Charlton

Cancer Causes & Control · 2024

DOI: 10.1007/s10552-024-01859-3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cancer Causes & Control, 2024. Verfasst von Emma L Herbach und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, USA. emma-herbach@uiowa.edu. Hauptthemen laut MEDLINE: Breast Neoplasms, Guideline Adherence, Medicare, SEER Program. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Geographic Management of Cancer Health Disparities, NCCDPHP CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To examine racial-ethnic variation in adherence to established quality metrics (NCCN guidelines and ASCO quality metrics) for breast cancer, accounting for individual-, facility-, and area-level factors. METHODS: Data from women diagnosed with invasive breast cancer at 66+ years of age from 2000 to 2017 were examined using SEER-Medicare. Associations between race and ethnicity and guideline-concordant diagnostics, locoregional treatment, systemic therapy, documented stage, and oncologist encounters were estimated using multilevel logistic regression models to account for clustering within facilities or counties. RESULTS: Black and American Indian/Alaska Native (AIAN) women had consistently lower odds of guideline-recommended care than non-Hispanic White (NHW) women (Diagnostic workup: ORBlack 0.83 (0.79-0.88), ORAIAN 0.66 (0.54-0.81); known stage: ORBlack 0.87 (0.80-0.94), ORAIAN 0.63 (0.47-0.85); seeing an oncologist: ORBlack 0.75 (0.71-0.79), ORAIAN 0.60 (0.47-0.72); locoregional treatment: ORBlack 0.80 (0.76-0.84), ORAIAN 0.84 (0.68-1.02); systemic therapies: ORBlack 0.90 (0.83-0.98), ORAIAN 0.66 (0.48-0.91)). Commission on Cancer accreditation and facility volume were significantly associated with higher odds of guideline-concordant diagnostics, stage, oncologist visits, and systemic therapy. Black residential segregation was associated with significantly lower odds of guideline-concordant locoregional treatment and systemic therapy. Rurality and area SES were associated with significantly lower odds of guideline-concordant diagnostics and oncologist visits. CONCLUSIONS: This is the first study to examine guideline-concordance across the continuum of breast cancer care from diagnosis to treatment initiation. Disparities were present from the diagnostic phase and persisted throughout the clinical course. Facility and area characteristics may facilitate or pose barriers to guideline-adherent treatment and warrant future investigation as mediators of racial-ethnic disparities in breast cancer care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGuideline AdherenceMedicareSEER ProgramAgedAged, 80 and overFemaleHumansEthnicityHealthcare DisparitiesPractice Guidelines as TopicUnited StatesBlack or African AmericanAmerican Indian or Alaska NativeWhite

Stichwörter der Autor:innen

Cancer care continuumEthnicityHealth disparitiesHealth equityMultilevel modelingRace

Autor:innen und Institutionen

  • Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, USA. emma-herbach@uiowa.edu.
  • Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA. emma-herbach@uiowa.edu.
  • Department of Community and Behavioral Health, College of Public Health, University of Iowa, Iowa City, IA, USA.
  • Department of Health Policy and Management, School of Global Public Health, University of North Carolina at Chapel Hill, Gillings, Chapel Hill, NC, USA.
  • Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, USA.
  • University of Iowa Holden Comprehensive Cancer Center, Iowa City, IA, USA.

Förderung

  • NCI NIH HHS
  • Geographic Management of Cancer Health Disparities
  • NCCDPHP CDC HHS
  • National Cancer Institute, United States

Zitieren

APA

Herbach, E. L., Curran, M., Roberson, M. L., Carnahan, R. M., McDowell, B. D., Wang, K., Lizarraga, I., Nash, S. H., & Charlton, M. (2024). Guideline-concordant breast cancer care by patient race and ethnicity accounting for individual-, facility- and area-level characteristics: a SEER-Medicare study. Cancer Causes & Control. https://doi.org/10.1007/s10552-024-01859-3

Vancouver

Herbach EL, Curran M, Roberson ML, Carnahan RM, McDowell BD, Wang K, et al. Guideline-concordant breast cancer care by patient race and ethnicity accounting for individual-, facility- and area-level characteristics: a SEER-Medicare study. Cancer Causes & Control. 2024. doi:10.1007/s10552-024-01859-3

BibTeX
@article{Herbach2024,
  author = {Herbach, Emma L and Curran, Michaela and Roberson, Mya L and Carnahan, Ryan M and McDowell, Bradley D and Wang, Kai and Lizarraga, Ingrid and Nash, Sarah H and Charlton, Mary},
  title = {Guideline-concordant breast cancer care by patient race and ethnicity accounting for individual-, facility- and area-level characteristics: a SEER-Medicare study},
  journal = {Cancer Causes & Control},
  year = {2024},
  doi = {10.1007/s10552-024-01859-3}
}
Kostenlos starten →